These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36034019)

  • 1. Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia.
    Bnina AB; Dhia RB; Gnaba S; Annabi A; Chouchane S; Naija W; Said H; Oueslati A; Bouatay A
    Pan Afr Med J; 2022; 42():110. PubMed ID: 36034019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
    Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
    Front Immunol; 2020; 11():584241. PubMed ID: 33178218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
    Oba S; Hosoya T; Kaneshige R; Kawata D; Yamaguchi T; Mitsumura T; Shimada S; Shibata S; Tateishi T; Koike R; Tohda S; Hirakawa A; Yoko N; Otomo Y; Nojima J; Miyazaki Y; Yasuda S
    Front Immunol; 2023; 14():1227547. PubMed ID: 37908357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit.
    Karahan S; Erol K; Yuksel RC; Artan C; Celik I
    Mod Rheumatol; 2022 Jan; 32(1):163-168. PubMed ID: 33620009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.
    Emmenegger M; Emmenegger V; Shambat SM; Scheier TC; Gomez-Mejia A; Chang CC; Wendel-Garcia PD; Buehler PK; Buettner T; Roggenbuck D; Brugger SD; Frauenknecht KBM
    Clin Immunol; 2023 Dec; 257():109845. PubMed ID: 37995947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?
    Lee EY; Lee CK; Lee TH; Chung SM; Kim SH; Cho YS; Yoo B; Moon HB
    Thromb Res; 2003; 111(1-2):29-32. PubMed ID: 14644075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Relationship Between Antiphospholipid Antibodies and COVID-19 Severity.
    Sadeghi A; Hasanlu M; Feyzi A; Mansori K; Ghodrati S; Parsamanesh N
    DNA Cell Biol; 2023 Jan; 42(1):65-71. PubMed ID: 36394439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
    Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
    Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA is the predominant isotype of anti-β2 glycoprotein I in patients with COVID-19.
    Melayah S; Omrani N; Alouini H; Ghozzi M; Mrad S; Boussarsar M; Chaouch H; Hachfi W; Letaief A; Mankaï A; Ghedira I
    Lab Med; 2024 May; 55(3):373-379. PubMed ID: 38124622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
    Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
    Front Immunol; 2022; 13():953043. PubMed ID: 36189273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.